Skip to main content

. 1986 Jan 4;292(6512):28. doi: 10.1136/bmj.292.6512.28

Use of topical lithium succinate for seborrhoeic dermatitis.

J Boyle, J L Burton, J Faergemann

PMCID: PMC1338980 PMID: 2935222

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Faergemann J., Fredriksson T. The antimycotic activity in vitro of five diols. Sabouraudia. 1980 Dec;18(4):287–293. [PubMed] [Google Scholar]
Ford G. P., Farr P. M., Ive F. A., Shuster S. The response of seborrhoeic dermatitis to ketoconazole. Br J Dermatol. 1984 Nov;111(5):603–607. doi: 10.1111/j.1365-2133.1984.tb06631.x. [DOI] [PubMed] [Google Scholar]
Heng M. C. Cutaneous manifestations of lithium toxicity. Br J Dermatol. 1982 Jan;106(1):107–109. doi: 10.1111/j.1365-2133.1982.tb00911.x. [DOI] [PubMed] [Google Scholar]
Lazarus G. S., Gilgor R. S. Psoriasis, polymorphonuclear leukocytes, and lithium carbonate. An important clue. Arch Dermatol. 1979 Oct;115(10):1183–1184. [PubMed] [Google Scholar]

ACTIONS

RESOURCES